Telesis Bio, Inc. (TBIO)
USD 0.29
(-1.72%)
USD 0.29
(-1.72%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -35.15 Million USD | 24.38% |
| 2022 | -46.48 Million USD | -31.41% |
| 2021 | -35.37 Million USD | -116.21% |
| 2020 | -16.36 Million USD | -134.53% |
| 2019 | -6.97 Million USD | 93.22% |
| 2018 | -102.96 Million USD | -30.45% |
| 2017 | -78.92 Million USD | -195.62% |
| 2016 | -26.69 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -8.52 Million USD | -39.87% |
| 2024 Q2 | -10.47 Million USD | -22.92% |
| 2023 Q3 | -10.12 Million USD | -27.05% |
| 2023 Q2 | -7.96 Million USD | 27.39% |
| 2023 Q4 | -6.09 Million USD | 39.81% |
| 2023 FY | -35.15 Million USD | 24.38% |
| 2023 Q1 | -10.97 Million USD | -39.16% |
| 2022 FY | -46.48 Million USD | -31.41% |
| 2022 Q1 | -12.86 Million USD | -6.33% |
| 2022 Q4 | -7.88 Million USD | 29.93% |
| 2022 Q3 | -11.25 Million USD | 22.34% |
| 2022 Q2 | -14.48 Million USD | -12.63% |
| 2021 FY | -35.37 Million USD | -116.21% |
| 2021 Q1 | -6.26 Million USD | -21.16% |
| 2021 Q2 | -7.57 Million USD | -20.88% |
| 2021 Q4 | -12.09 Million USD | -28.13% |
| 2021 Q3 | -9.44 Million USD | -24.68% |
| 2020 Q1 | -3.59 Million USD | 88.42% |
| 2020 Q2 | -3.29 Million USD | 8.32% |
| 2020 Q3 | -4.3 Million USD | -30.46% |
| 2020 Q4 | -5.17 Million USD | -20.23% |
| 2020 FY | -16.36 Million USD | -134.53% |
| 2019 Q4 | -31.03 Million USD | -46.21% |
| 2019 FY | -6.97 Million USD | 93.22% |
| 2019 Q3 | -21.22 Million USD | 23.73% |
| 2019 Q2 | -27.83 Million USD | 17.37% |
| 2019 Q1 | -33.68 Million USD | -420.14% |
| 2018 Q1 | -22.31 Million USD | 9.12% |
| 2018 Q2 | -29 Million USD | -29.99% |
| 2018 Q3 | -45.17 Million USD | -55.74% |
| 2018 Q4 | -6.47 Million USD | 85.66% |
| 2018 FY | -102.96 Million USD | -30.45% |
| 2017 FY | -78.92 Million USD | -195.62% |
| 2017 Q1 | -14.8 Million USD | 0.0% |
| 2017 Q2 | -18.8 Million USD | -27.0% |
| 2017 Q3 | -20.76 Million USD | -10.43% |
| 2017 Q4 | -24.55 Million USD | -18.24% |
| 2016 FY | -26.69 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -144.76% |
| Cerus Corporation | -30.05 Million USD | -16.96% |
| OrthoPediatrics Corp. | -25.76 Million USD | -36.42% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -230.938% |
| Talis Biomedical Corporation | -66.81 Million USD | 47.392% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -103.226% |
| Inogen, Inc. | -109.38 Million USD | 67.866% |
| Spectral AI, Inc. | -12.98 Million USD | -170.718% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 43.84% |
| CVRx, Inc. | -43.1 Million USD | 18.451% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -896.315% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -182.829% |
| Orthofix Medical Inc. | -139.11 Million USD | 74.732% |
| Venus Concept Inc. | -28.3 Million USD | -24.165% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 34.941% |
| Bioventus Inc. | -81.72 Million USD | 56.99% |
| BrainsWay Ltd. | -4.92 Million USD | -613.416% |
| Envoy Medical, Inc. | -18.37 Million USD | -91.334% |
| electroCore, Inc. | -18.8 Million USD | -86.918% |
| IceCure Medical Ltd | -15.57 Million USD | -125.668% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 27.499% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -103.555% |
| MaxCyte, Inc. | -48.29 Million USD | 27.224% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -194.013% |
| Nexalin Technology, Inc. | -5.69 Million USD | -517.068% |
| PAVmed Inc | -68.79 Million USD | 48.906% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 37.857% |
| RxSight, Inc. | -50.08 Million USD | 29.819% |
| Sight Sciences, Inc. | -57.27 Million USD | 38.628% |
| SI-BONE, Inc. | -46.93 Million USD | 25.103% |
| TELA Bio, Inc. | -44.07 Million USD | 20.25% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 35.088% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 31.652% |
| LivaNova PLC | -68.49 Million USD | 48.685% |
| 908 Devices Inc. | -42.75 Million USD | 17.793% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 79.728% |
| Nemaura Medical Inc. | -9.59 Million USD | -266.328% |
| NeuroPace, Inc. | -27.17 Million USD | -29.352% |
| LENSAR, Inc. | -12.22 Million USD | -187.432% |
| Apyx Medical Corporation | -17.25 Million USD | -103.662% |
| Cutera, Inc. | -156.23 Million USD | 77.501% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -308.531% |
| BioSig Technologies, Inc. | -28.51 Million USD | -23.281% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 59.892% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -56.598% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 131.517% |
| Axonics, Inc. | -26.05 Million USD | -34.897% |
| Outset Medical, Inc. | -169.77 Million USD | 79.296% |
| IRIDEX Corporation | -10 Million USD | -251.254% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 67.803% |
| IRadimed Corporation | 20.03 Million USD | 275.439% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -326.319% |
| INVO Bioscience, Inc. | -6.76 Million USD | -419.421% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 345.29% |
| Varex Imaging Corporation | 32.1 Million USD | 209.502% |
| Quipt Home Medical Corp. | 3.91 Million USD | 996.912% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -189.706% |
| Pulmonx Corporation | -61.93 Million USD | 43.247% |
| Dynatronics Corporation | -2.27 Million USD | -1446.382% |
| Modular Medical, Inc. | -17.52 Million USD | -100.525% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -140.112% |
| Semler Scientific, Inc. | 22.25 Million USD | 257.935% |
| InMode Ltd. | 195.66 Million USD | 117.965% |
| Bruker Corporation | 436.9 Million USD | 108.045% |
| Cytosorbents Corporation | -31.2 Million USD | -12.627% |
| DexCom, Inc. | 597.7 Million USD | 105.881% |
| Align Technology, Inc. | 643.33 Million USD | 105.464% |
| Viveve Medical, Inc. | -21.55 Million USD | -63.086% |
| ZimVie Inc. | -30.93 Million USD | -13.611% |
| Movano Inc. | -29.69 Million USD | -18.39% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -26.235% |
| Nexalin Technology, Inc. | -5.69 Million USD | -517.068% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -896.315% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 84.929% |
| Profound Medical Corp. | -28.61 Million USD | -22.833% |
| Insulet Corporation | 220 Million USD | 115.977% |
| enVVeno Medical Corporation | -25.23 Million USD | -39.274% |
| Surmodics, Inc. | -5.64 Million USD | -522.675% |
| iCAD, Inc. | -7.68 Million USD | -357.147% |
| Nuwellis, Inc. | -17.63 Million USD | -99.376% |
| Biotricity, Inc. | -8.82 Million USD | -298.153% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 71.916% |
| Aethlon Medical, Inc. | -12.63 Million USD | -178.161% |
| InspireMD, Inc. | -21.14 Million USD | -66.249% |
| PAVmed Inc. | -68.79 Million USD | 48.906% |
| BIOLASE, Inc. | -17.93 Million USD | -95.964% |
| Beyond Air, Inc. | -63 Million USD | 44.212% |
| FONAR Corporation | 16.53 Million USD | 312.575% |
| AxoGen, Inc. | -21.46 Million USD | -63.778% |
| Vivani Medical, Inc. | -26.96 Million USD | -30.354% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 294.834% |
| Inari Medical, Inc. | -14.03 Million USD | -150.499% |
| UFP Technologies, Inc. | 57.66 Million USD | 160.957% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -613.329% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -457.426% |
| Tenon Medical, Inc. | -15.72 Million USD | -123.501% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -370.297% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 17.694% |
| AdaptHealth Corp. | -598.4 Million USD | 94.126% |
| Sintx Technologies, Inc. | -13.35 Million USD | -163.138% |
| NanoVibronix, Inc. | -3.43 Million USD | -922.992% |
| Quanterix Corporation | -49.7 Million USD | 29.277% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -189.706% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -9101.571% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 89.491% |
| TransMedics Group, Inc. | -28.72 Million USD | -22.359% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -48.865% |
| NeuroMetrix, Inc. | -7.15 Million USD | -391.504% |
| Hyperfine, Inc. | -48.11 Million USD | 26.946% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 45.945% |
| Biomerica, Inc. | -6.36 Million USD | -452.065% |
| Bone Biologics Corporation | -9.42 Million USD | -272.814% |
| AVITA Medical, Inc. | -40.4 Million USD | 13.0% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -240.891% |
| Silk Road Medical, Inc | -59.27 Million USD | 40.696% |